Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Charles River Laboratories International, Inc.

< Previous 1 2 3 4 5 Next >
Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces First-Quarter 2023 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at Barclays Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Acquires SAMDI Tech
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches CliniPrime Suite of GMP-Compliant Cellular Products
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at November Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Third-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.